Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United Kingdom
/
Pharmaceuticals & Biotech
Create a narrative
hVIVO
AIM:HVO Community
1
Narratives
written by author
0
Comments
on narratives written by author
22
Fair Values set
on narratives written by author
Create a narrative
hVIVO
Popular
Undervalued
Overvalued
hVIVO
WA
Analyst Price Target
Consensus Narrative from 7 Analysts
Expansion Into New Canary Wharf Facility Will Increase Capacity But Challenges In Sustaining Margins May Arise
Key Takeaways Expansion into a new facility and offering new services are expected to drive revenue growth and diversify income streams. Increased capacity for trials and focus on operational efficiencies could improve margins and enhance overall revenue.
View narrative
UK£0.33
FV
45.5% undervalued
intrinsic discount
6.88%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
13 days ago
author updated this narrative
Your Valuation for
HVO
hVIVO
Your Fair Value
UK£
Current Price
UK£0.18
6.6% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-11m
104m
2015
2018
2021
2024
2025
2027
2030
Revenue UK£103.9m
Earnings UK£27.0m
Advanced
Set as Fair Value